cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Eli Lilly And Company
198 own
79 watching
Current Price
$348.01
$-1.72
(-0.49%)
logo-lly
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
330,827.7M
52-Week High
52-Week High
384.44
52-Week Low
52-Week Low
231.87
Average Volume
Average Volume
2.57M
Dividend Yield
Dividend Yield
0.012415
P/E Ratio
P/E Ratio
40.4129
iconMarket Capitalization330,827.7M
icon52-Week High384.44
icon52-Week Low231.87
iconAverage Volume2.57M
iconDividend Yield0.012415
iconP/E Ratio40.4129
What does the Eli Lilly And Company do?
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. It operates through two segments, Human Pharmaceutical Products and Animal Health Products. The company offers endocrinology products to treat diabetes; osteoporosis in postmenopausal women and men; human growth hormone deficiency and pediatric growth conditions; and testosterone deficiency. It also provides neuroscience products for the treatment of depressive disorders, diabetic peripheral neuropathic pain, anxiety disorders, fibromyalgia, and chronic musculoskeletal pain; schizophrenia; attention-deficit hyperactivity disorders; depressive, obsessive-compulsive, bulimia nervosa, and panic disorders; and positron emission tomography imaging of beta-amyloid neurotic plaques in adult brains. In addition, the company offers products to treat non-small cell lung, colorectal, head and neck, pancreatic, metastatic breast, ovarian, bladder, and metastatic gastric cancers, as well as malignant pleural mesothelioma; and cardiovascular products to treat erectile dysfunction and benign prostatic hyperplasia; and migraine headaches. Further, it provides animal health products, such as cattle feed additives; protein supplements for cows; leanness and performance enhancers for swine and cattle; antibiotics to treat respiratory and other diseases in cattle, swine, and poultry; anticoccidial agents for poultry; and chewable tablets that kill fleas and prevent flea infestations, and heartworm diseases, as well as controls intestinal parasite infections. Additionally, the company offers vaccinev to prevent Lyme disease, bronchial infections, rabies, and various infectious diseases in dogs, cats, and horses. It has collaboration agreements with Daiichi Sankyo Co., Ltd., Incyte Corporation, Pfizer Inc., AstraZeneca, and William Sansum Diabetes Center. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Read More
How much money does Eli Lilly And Company make?
News & Events about Eli Lilly And Company.
Accesswire
7hours ago
INDIANAPOLIS, IN and SANTA BARBARA, CA / ACCESSWIRE / January 26, 2023 / Direct Relief:Eli Lilly and Company (NYSE:LLY) and Direct Relief today announced a new initiative to expand access to medicines in low- and middle-income countries by boosting cold chain capacity in 17 countries. Supported by...
Abnormal Returns
2days ago
MarketsWe are in the strongest part of the Presidential election cycle. (allstarcharts.com)Why value stocks can outperform for a while. (mailchi.mp)StrategyDon't let any investment become your identity. (youngmoney.co)Why it's so hard not to tinker with your investment process. (...
MarketWatch.com
6days ago
The setback could delay a potential commercial introduction of the highly anticipated drug by at least several months, if the Food and Drug Administration eventually decides to approve it...
PR Newswire
6days ago
US FDA accepts supplemental New Drug Application for Jardiance for adults with chronic kidney disease US FDA accepts supplemental New Drug Application for Jardiance for adults with chronic kidney disease PR Newswire RIDGEFIELD, Conn. and INDIANAPOLIS, Jan. 20, 2023 The supplemental New Drug...
PR Newswire
7days ago
Lilly Confirms Date and Conference Call for Fourth-Quarter 2022 Financial Results Announcement Lilly Confirms Date and Conference Call for Fourth-Quarter 2022 Financial Results Announcement PR Newswire INDIANAPOLIS, Jan. 19, 2023 INDIANAPOLIS, Jan. 19, 2023 /PRNewswire/ -- Eli Lilly and Company...
Frequently Asked Questions
Frequently Asked Questions
What is Eli Lilly And Company share price today?
plus_minus_icon
Can Indians buy Eli Lilly And Company shares?
plus_minus_icon
How can I buy Eli Lilly And Company shares from India?
plus_minus_icon
Can Fractional shares of Eli Lilly And Company be purchased?
plus_minus_icon
What are the documents required to start investing in Eli Lilly And Company stocks?
plus_minus_icon
What is today’s traded volume of Eli Lilly And Company?
plus_minus_icon
What is today’s market capitalisation of Eli Lilly And Company?
plus_minus_icon
What is the 52-Week High and Low Range of Eli Lilly And Company?
plus_minus_icon
What percentage is Eli Lilly And Company down from its 52-Week High?
plus_minus_icon
What percentage is Eli Lilly And Company up from its 52-Week Low?
plus_minus_icon
Current Price
$348.01
$-1.72
(-0.49%)
logo-lly
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
AbbVie Inc.
AbbVie Inc.
$147.40
$-0.39 (-0.26 %)
Novartis AG
Novartis AG
$89.84
$-2.97 (-3.20 %)
Merck & Co. Inc.
Merck & Co. Inc.
$106.87
$-1.72 (-1.58 %)
Johnson & Johnson
Johnson & Johnson
$168.89
$-0.62 (-0.37 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
AbbVie Inc.
AbbVie Inc.
$147.40
$-0.39 (-0.26 %)
Novartis AG
Novartis AG
$89.84
$-2.97 (-3.20 %)
Merck & Co. Inc.
Merck & Co. Inc.
$106.87
$-1.72 (-1.58 %)
Johnson & Johnson
Johnson & Johnson
$168.89
$-0.62 (-0.37 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00